about
Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosisGold on paper-paper platform for Au-nanoprobe TB detection.Mobile based gold nanoprobe TB diagnostics for point-of-need.Single nucleotide polymorphism detection using gold nanoprobes and bio-microfluidic platform with embedded microlenses.One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care.AuNPs for identification of molecular signatures of resistance.Field effect sensors for nucleic Acid detection: recent advances and future perspectives.Quantitative real-time monitoring of RCA amplification of cancer biomarkers mediated by a flexible ion sensitive platform.A low cost, safe, disposable, rapid and self-sustainable paper-based platform for diagnostic testing: lab-on-paper.Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis.Digital Microfluidics for Nucleic Acid Amplification.Portable optoelectronic biosensing platform for identification of mycobacteria from the Mycobacterium tuberculosis complex.Isothermal DNA amplification coupled to Au-nanoprobes for detection of mutations associated to Rifampicin resistance in Mycobacterium tuberculosisAllele specific LAMP- gold nanoparticle for characterization of single nucleotide polymorphisms.A Digital Microfluidics Platform for Loop-Mediated Isothermal Amplification Detection.Real-time monitoring of PCR amplification of proto-oncogene c-MYC using a Ta₂O₅ electrolyte-insulator-semiconductor sensor.Ion sensing (EIS) real-time quantitative monitorization of isothermal DNA amplification.Au-nanoprobes for detection of SNPs associated with antibiotic resistance inMycobacterium tuberculosisGLUT1 and GLUT3 involvement in anthocyanin gastric transport- Nanobased targeted approachBio-microfluidic platform for gold nanoprobe based DNA detection--application to Mycobacterium tuberculosisFast Prototyping Microfluidics: Integrating Droplet Digital Lamp for Absolute Quantification of Cancer BiomarkersAntibody modified gold nanoparticles for fast colorimetric screening of rheumatoid arthritis
P50
Q28482174-5CBD8DF1-50BC-4B16-AD10-3A84C7E9D29AQ33439092-8C884922-6FA0-4A8C-86C0-F8FC5D0A1384Q33442650-B6C1C841-B8EB-4D66-AFB7-6DB6CE78D76FQ35576067-C66CFBC4-91BE-475B-A435-ABF30B5023B8Q35922933-A79BE7B7-0B56-43EE-95D3-A521584157FCQ38249184-604CC81C-846B-41B1-837F-CD88482279ECQ38462373-12758833-E263-4202-9FE7-E5D9A45D0A80Q38718598-260EDFB7-95F1-4CE8-9900-909DAD38BB30Q39251545-5357BCA4-1B5D-43C3-91FF-1C9748F722B8Q39346142-F3D1832A-A55D-4F31-8C3B-59712407DFE2Q39411629-99036B57-EF9F-4523-AA34-F966F080DAA1Q39952540-72F3D84C-ABD1-425C-B86B-78D788E95181Q42118550-F68ED9E8-4411-49A5-91B2-677F91FDDE40Q45893225-3B0A1247-A0AA-421D-B856-F3AE293D920EQ47128252-7C20ABC9-C800-48BB-AE7F-B6E3B8B247DEQ50515284-2E63675F-EE07-49C1-A9E7-EDFB91F54408Q51785879-E0993006-96D7-4FEF-AAA6-47121B329E4AQ57657226-897F131A-489F-48C2-A1B7-3E6EC28C3B03Q61443431-226C8C56-6909-4D75-BC2D-E55841A3D37AQ86754489-40C29BEE-6B57-42CC-814F-DC22D43347A8Q90399788-048E3323-BE6C-473B-B48A-B50123C68CBBQ91879218-092119DB-E43E-41D8-A84E-277F939F5F6A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bruno Veigas
@ast
Bruno Veigas
@en
Bruno Veigas
@es
Bruno Veigas
@nl
type
label
Bruno Veigas
@ast
Bruno Veigas
@en
Bruno Veigas
@es
Bruno Veigas
@nl
prefLabel
Bruno Veigas
@ast
Bruno Veigas
@en
Bruno Veigas
@es
Bruno Veigas
@nl
P106
P21
P2456
P31
P496
0000-0002-9265-4591